Basics Kiniksa Pharmaceuticals, Ltd. IPO Date: May 21, 2018 Sector: Healthcare Industry: Biotech Market Cap: $3.16B Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 2.67% Avg Daily Range (30 D): $0.60 | 1.50% Avg Daily Range (90 D): $0.51 | 1.38% Institutional Daily Volume Avg Daily Volume: .29M Avg Daily Volume (30 D): .35M Avg Daily Volume (90 D): .38M Trade Size Avg Trade Size (Sh.): 69 Avg Trade Size (Sh.) (30 D): 53 Avg Trade Size (Sh.) (90 D): 51 Institutional Trades Total Inst.Trades: 1,568 Avg Inst. Trade: $1.72M Avg Inst. Trade (30 D): $1.62M Avg Inst. Trade (90 D): $1.91M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.71M Avg Closing Trade (30 D): $1.92M Avg Closing Trade (90 D): $2M Avg Closing Volume: 84.67K     News Oct 17, 2025 @ 12:00 PM Kiniksa Pharmaceuticals Announces U.S. Orphan Drug... Source: Kiniksa Pharmaceuticals International Jun 5, 2025 @ 11:00 AM Kiniksa Pharmaceuticals Announces Trial Design of ... Source: N/A May 29, 2025 @ 8:01 PM Kiniksa Pharmaceuticals to Present at Upcoming Inv... Source: N/A Mar 14, 2025 @ 9:51 AM 3 No-Brainer Healthcare Stocks to Buy With $1,000 ... Source: Keith Speights Feb 20, 2025 @ 9:01 PM Kiniksa Pharmaceuticals to Report Fourth Quarter a... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $.49 $.25 $.24 Diluted EPS $.45 $.23 $.23 Revenue $ 597.97M $ 180.86M $ 156.8M Gross Profit $ 523.35M $ 160.6M $ 138.19M Net Income / Loss $ 35.92M $ 18.44M $ 17.83M Operating Income / Loss $ 38.15M $ 24.02M $ 20.16M Cost of Revenue $ 74.62M $ 20.26M $ 18.6M Net Cash Flow $ 77.48M $ -17.18M $ 34.91M PE Ratio 92.29